FDA sets meetings to discuss Moderna and Pfizer COVID-19 vaccines
Both companies say their vaccines are 95% effective.
•
Nov 24, 2020, 11:45 AM
•
Updated 1,340 days ago
Share:
More Stories
Hometown Heroes in the Hudson Valley
2ds ago1:28
Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines
146ds ago1:52
Judge: 3 men convicted in COVID-19 relief aid fraud
167ds ago1:47
Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off
294ds ago0:28
Rockland small businesses get COVID-19 reimbursement grant
295ds ago
Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
298ds agoHometown Heroes in the Hudson Valley
2ds ago1:28
Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines
146ds ago1:52
Judge: 3 men convicted in COVID-19 relief aid fraud
167ds ago1:47
Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off
294ds ago0:28
Rockland small businesses get COVID-19 reimbursement grant
295ds agoNobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
298ds agoThe United States Food and Drug
Administration (FDA or USFDA) has scheduled meetings
in order to approve two
COVID-19 vaccines.
The agency has asked members
of its vaccine advisory committee to reserve Dec. 17
and 18 for meetings.
A source says those meetings
are to discuss Moderna's vaccine.
Another meeting has already
been set for Dec. 10, and will focus on Pfizer's
application for emergency use approval.
Both companies say their
vaccines are 95% effective.
